We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,610

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHRT icon
12351
CALL
iHeartMedia
IHRT
$457M
$30.3K ﹤0.01%
+16,400
New +$24.4K
INZY
12352
PUT
DELISTED
Inozyme Pharma
INZY
$30.3K ﹤0.01%
5,800
+3,100
+115% +$16.1K
LONA
12353
PUT
LeonaBio Inc
LONA
$74.8M
$30.3K ﹤0.01%
6,800
+5,510
+427% +$129K
CLRO icon
12354
ClearOne Inc
CLRO
$14M
$30.3K ﹤0.01%
3,265
+2,370
+265% +$22.5K
KPTI icon
12355
PUT
Karyopharm Therapeutics
KPTI
$45.8M
$30.3K ﹤0.01%
2,433
+786
+48% +$9.77K
SATX
12356
DELISTED
SatixFy Communications
SATX
$30.3K ﹤0.01%
+42,839
New +$29.5K
BCSF icon
12357
Bain Capital Specialty
BCSF
$814M
$30.3K ﹤0.01%
1,824
-82,068
-98% -$1.36M
CCU icon
12358
CALL
Compañía de Cervecerías Unidas
CCU
$2.18B
$30.2K ﹤0.01%
+2,600
New +$29.1K
TDUP icon
12359
CALL
ThredUp
TDUP
$403M
$30.2K ﹤0.01%
35,900
+30,800
+604% +$37.6K
CLPR
12360
CALL
Clipper Realty
CLPR
$54M
$30.2K ﹤0.01%
5,300
-14,000
-73% -$62.7K
NCL icon
12361
Northann Corp
NCL
$30.2K ﹤0.01%
20,970
+15,461
+281% +$26K
GP
12362
CALL
GreenPower Motor Co
GP
$13M
$30.1K ﹤0.01%
2,200
+1,530
+228% +$16.7K
JSPR icon
12363
PUT
Jasper Therapeutics
JSPR
$26.3M
$30.1K ﹤0.01%
+1,600
New +$31.9K
AUR icon
12364
Aurora
AUR
$13.7B
$30.1K ﹤0.01%
5,076
-1,356,848
-100% -$5.65M
AEG icon
12365
CALL
Aegon
AEG
$14B
$30K ﹤0.01%
4,700
-2,600
-36% -$16.1K
CATO icon
12366
CALL
Cato Corp
CATO
$67.9M
$29.9K ﹤0.01%
6,000
-200
-3% -$985
NAGE
12367
PUT
Niagen Bioscience
NAGE
$239M
$29.9K ﹤0.01%
8,200
+2,100
+34% +$6.61K
NOA
12368
PUT
North American Construction
NOA
$375M
$29.9K ﹤0.01%
1,600
-6,000
-79% -$113K
EPSN icon
12369
CALL
Epsilon Energy
EPSN
$169M
$29.9K ﹤0.01%
+5,100
New +$27.3K
MNY icon
12370
CALL
MoneyHero
MNY
$40.1M
$29.9K ﹤0.01%
27,400
+17,200
+169% +$23.9K
STLN
12371
Starling Oncology
STLN
$657M
$29.9K ﹤0.01%
91,337
-178,367
-66% -$73.9K
XBP icon
12372
XBP Global Holdings
XBP
$33.1M
$29.8K ﹤0.01%
+2,789
New +$36.2K
LXRX icon
12373
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
$29.8K ﹤0.01%
19,000
-23,700
-56% -$42.2K
FTEK icon
12374
CALL
Fuel Tech
FTEK
$45.3M
$29.8K ﹤0.01%
28,400
+28,200
+14,100% +$28.9K
ENZ
12375
DELISTED
Enzo Biochem, Inc.
ENZ
$29.8K ﹤0.01%
+26,594
New +$29.8K

Similar funds

Ken Griffin's Q3 2024 Portfolio in Review

As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
  • Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.